Dr Gareth Gerrard
@ggerrard.bsky.social
Clinical Scientist at Guy's & St. Thomas' NHS Trust and Scientific Director of the South East Genomic Laboratory Hub (SEGLH) / Synnovis Genomics.
Some opportunistic snaps while walking to the RCPath to attend day 1 of the CERSI-PGx Workshop yesterday morning - some very excellent work being done - more again today..!
January 21, 2026 at 8:01 AM
Some opportunistic snaps while walking to the RCPath to attend day 1 of the CERSI-PGx Workshop yesterday morning - some very excellent work being done - more again today..!
Reposted by Dr Gareth Gerrard
A vaccine to prevent colon cancer.
Proof-of-concept for strong immune response and safety via neoantigens given to people carrying mutations for Lynch syndrome
nature.com/articles/s41...
Proof-of-concept for strong immune response and safety via neoantigens given to people carrying mutations for Lynch syndrome
nature.com/articles/s41...
Nous-209 neoantigen vaccine for cancer prevention in Lynch syndrome carriers: a phase 1b/2 trial - Nature Medicine
In a phase 1b/2 trial, an off-the-shelf vaccine using gorilla adenoviral and modified vaccinia Ankara vectors with over 200 mutated peptides known to be present in persons with mismatch-repair-deficie...
nature.com
January 16, 2026 at 4:27 PM
A vaccine to prevent colon cancer.
Proof-of-concept for strong immune response and safety via neoantigens given to people carrying mutations for Lynch syndrome
nature.com/articles/s41...
Proof-of-concept for strong immune response and safety via neoantigens given to people carrying mutations for Lynch syndrome
nature.com/articles/s41...
Moody morning commute snap - Rochester Cathedral from the train
January 16, 2026 at 8:46 AM
Moody morning commute snap - Rochester Cathedral from the train